Haemonetics Corp. (HAE)
108.40
-0.40
(-0.37%)
USD |
NYSE |
Aug 24, 16:00
108.00
-0.40
(-0.37%)
Pre-Market: 07:29
Haemonetics Net Income (Quarterly) : 33.01M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.01M |
| March 31, 2026 | -20.15M |
| December 31, 2025 | 44.74M |
| September 30, 2025 | 38.68M |
| June 30, 2025 | 34.03M |
| March 31, 2025 | 57.98M |
| December 31, 2024 | 37.49M |
| September 30, 2024 | 33.83M |
| June 30, 2024 | 38.37M |
| March 31, 2024 | 20.37M |
| December 31, 2023 | 31.24M |
| September 30, 2023 | 24.91M |
| June 30, 2023 | 41.04M |
| March 31, 2023 | 29.38M |
| December 31, 2022 | 32.94M |
| September 30, 2022 | 33.20M |
| June 30, 2022 | 19.88M |
| March 31, 2022 | 9.741M |
| December 31, 2021 | 23.23M |
| September 30, 2021 | 14.86M |
| June 30, 2021 | -4.454M |
| March 31, 2021 | -11.04M |
| December 31, 2020 | 31.88M |
| September 30, 2020 | 48.10M |
| June 30, 2020 | 10.53M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.62M |
| December 31, 2019 | 29.90M |
| September 30, 2019 | 37.49M |
| June 30, 2019 | -8.479M |
| March 31, 2019 | 20.84M |
| December 31, 2018 | 18.28M |
| September 30, 2018 | 18.73M |
| June 30, 2018 | -2.819M |
| March 31, 2018 | 11.88M |
| December 31, 2017 | -6.547M |
| September 30, 2017 | 20.10M |
| June 30, 2017 | 20.14M |
| March 31, 2017 | -51.14M |
| December 31, 2016 | 15.39M |
| September 30, 2016 | 19.82M |
| June 30, 2016 | -10.35M |
| March 31, 2016 | -8.776M |
| December 31, 2015 | -59.44M |
| September 30, 2015 | 12.86M |
| June 30, 2015 | -0.267M |
| March 31, 2015 | -2.93M |
| December 31, 2014 | 15.99M |
| September 30, 2014 | 7.487M |
| June 30, 2014 | -3.649M |
| March 31, 2014 | 10.18M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Boston Scientific Corp. | 905.00M |
| Integra LifeSciences Holdings Corp. | 4.482M |
| Globus Medical, Inc. | 151.57M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 339.38M |
| Total Expenses (Quarterly) | 306.37M |
| EPS Diluted (Quarterly) | 0.7223 |
| Enterprise Value | 5.880B |
| Gross Profit Margin (Quarterly) | 56.98% |
| Profit Margin (Quarterly) | 9.73% |
| Earnings Yield | 1.89% |
| Operating Earnings Yield | 4.91% |
| Normalized Earnings Yield | 3.083 |